Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENEVIEVE: Cabazitaxel vs Paclitaxel in Neoadjuvant Breast Cancer
NCT01779479Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- Feb 2013
- Primary completion
- Aug 2015
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in breast cancer, sponsored by GBG Forschungs. Started Feb 2013; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01779479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779479.